Epalrestat
Epalrestat CAS-nr.: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat wurdt brûkt om perifeare neuropaty te foarkommen, te ferbetterjen en te behanneljen (dommens, pine), trillingsparesthesia, en kardiale abnormaliteit ferbûn mei diabetes. SPESIFIKASJE
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat wurdt brûkt om perifeare neuropaty te foarkommen, te ferbetterjen en te behanneljen (dommens, pine), trillingsparesthesia, en kardiale abnormaliteit ferbûn mei diabetes. SPESIFIKASJE
P rodukt namme | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Skriuw jo berjocht hjir en stjoer it nei ús